by bd@accellclinical.com | Feb 6, 2023
Since January 31, 2023, under the Clinical Trials Regulation, all initial clinical trial applications in the European Union must be submitted via a single EU portal – CTIS. Accell is ready to embrace the change.
by bd@accellclinical.com | Aug 10, 2022
In July 2022, Romania harmonized its regulatory approval procedures to secure clinical trials start-up timelines in accordance with the EU Regulation.
by bd@accellclinical.com | Sep 28, 2018
GHP magazine announced Accell Clinical Research as one of the winners of the Healthcare & Pharmaceutical Awards 2018, ‘The Best Clinical Trial Management Firm – Eastern Europe’.
by bd@accellclinical.com | Feb 8, 2018
Julia Kondakov, Director of Business Development at Accell Clinical Research, explains why Russia is a gateway to strong patient recruitment for oncology trials. Written for Pharmafocus: “Collaborations in Oncology 2016”.
by bd@accellclinical.com | Dec 29, 2017
Dr. Natalia Nayanova reveals myths and realities on the subject of clinical trials in Russia, Eastern Europe, and CIS at ‘Nordic Life Science Days’ in Stockholm, Sweden.
by bd@accellclinical.com | Dec 14, 2017
Discover how Russian healthcare system impacts the success of oncology clinical trials. Julia Kondakov provides valuable insights in her presentation.
by bd@accellclinical.com | Dec 14, 2015
A presentation was given by Dr. Natalia Nayanova, Director of Clinical Operations at Accell, at ‘Clinical Trials Innovation Programme’ in Frankfurt, Germany.
Recent Comments